|
01
|
Celera-Sequencing the Human Genome
|
|
02
|
Complementary DNA Sequencing-paper abstract
|
|
03
|
Cover of Science
|
|
04
|
Completed Microbial Genomes-timeline
|
|
05
|
Genomes Sequenced at TIGR and Celera
|
|
06
|
Genesis of Celera August 1998
|
|
07
|
Celera's Sequencing/ SNP Discovery Center
|
|
08
|
Celera Supercomputing Facility
|
|
09
|
NY Times- On Road to Human Genome
|
|
10
|
Obstacles to Genome Sequencing
|
|
11
|
Comparison of Sequencing Strategies
|
|
12
|
Clone by Clone Shotgun Sequencing
|
|
13
|
Mate-Pair Shotgun DNA Sequencing
|
|
14
|
Whole Genome Sequencing Approaches
|
|
15
|
Building Scaffolds
|
|
16
|
3-10 pairs link each consecutive contig
|
|
17
|
Validation against STS-map
|
|
18
|
"Annotation Jamboree"
|
|
19
|
Drosophila genes and their roles-pie chart
|
|
20
|
Cover of Science
|
|
21
|
Haemophilus vs Drosophila
|
|
22
|
Human chromosomes
|
|
23
|
Human Genome Sequence Milestones
|
|
24
|
Dr. Venter at White House, June 2000
|
|
25
|
Cover of Science-The Human Genome
|
|
26
|
Components vs GeneMap '99
|
|
27
|
Order and Orientation is Essential to Finding Genes
|
|
28
|
Scaffold Sizes
|
|
29
|
Gene Number in the Human Genome
|
|
30
|
The Human Genome is NOT...
|
|
31
|
Gene Map
|
|
32
|
Adrenaline Receptor
|
|
33
|
Gene Map
|
|
34
|
Molecular Function of Predicted proteins
|
|
35
|
Mouse Genome Status
|
|
36
|
Mouse/Human Comparison
|
|
37
|
Down Syndrome: Human Mouse Systemy
|
|
38
|
Conservation of Gene Sequence
|
|
39
|
Conservation of Coding Sequence
|
|
40
|
Mouse 16/Human 21 Genetic Schematic Map
|
|
41
|
Linear Schematic of Mouse/Human Data
|
|
42
|
Computed Mouse/Human Orthologs
|
|
43
|
Conservation of Regulatory Signals
|
|
44
|
Nucleotide Differences between Human/Chimpanzee Genomes
|
|
45/24
|
Human vs Chimpanzee Histamine (H1) Receptor
|
|
45/25
|
Human vs Chimpanzee Histamine (H1) Receptor
|
|
46
|
Human proline oxidase gene
|
|
47
|
Large Scale Duplication
|
|
48/4
|
Duplications within the Human Genome (a)
|
|
48/5
|
Duplications within the Human Genome (b)
|
|
48/6
|
Duplications within the Human Genome (c)
|
|
48
|
Duplications within the human genome
|
|
49
|
Genome Duplications in C. elegans
|
|
50
|
Syntenic Blocks between C. elegans and Human
|
|
51
|
Genetic Variation
|
|
52
|
Human Genome Exon and Regulatory Region Resequencing Project
|
|
53
|
Resequencing Program-40 Individuals
|
|
54
|
Human Genome Exon and Regulatory Region Resequencing Project
|
|
55
|
Human Genome Exon and Regulatory Region Resequencing Project-SNPs identified
|
|
56/1
|
CCR5 gene/significant HIV resistance/Caucasians & Blacks
|
|
56/2
|
CCR5 gene/significant HIV resistance/Caucasians vs Blacks
|
|
56
|
Human polymorphisms involved in susceptibility/progression of HIV infection
|
|
57
|
DNA Mismatch Repair
|
|
58/4
|
Molecular Medicine Paradigm (a)
|
|
58/7
|
Molecular Medicine Paradigm (b)
|
|
59
|
Proteomics Factory
|
|
60
|
Proteomics Lab
|
|
61
|
Cancer Specific Vaccines
|
|
62/10
|
Evolving Levels of Information (a)
|
|
62/23
|
Evolving Levels of Information (b)
|
|
62
|
Celera Discovery Sciences
|
